| albuterol sulfate / Generic mfg. |
NCT06154304: BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma |
|
|
| Not yet recruiting | 3 | 120 | US | Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation), Albuterol Test Product, Ventolin HFA 90Mcg/Actuation Inhalation Aerosol_#1, Albuterol Reference Product, Ventolin HFA, 90 Mcg/Inh Inhalation Aerosol_#2, Placebo | Cipla Ltd. | Bronchial Asthma | 08/24 | 09/24 | | |
BREATH, NCT06245551: A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma |
|
|
| Completed | 3 | 64 | RoW | Budesonide/albuterol metered-dose inhaler 160/180 μg, PT027 (BDA MDI) 160/180 μg, Placebo metered-dose inhaler, Placebo MDI | AstraZeneca | Asthma, Exercise-Induced | 06/24 | 06/24 | | |
NCT06052267: A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations |
|
|
| Recruiting | 3 | 2196 | Europe, Canada, US, RoW | TEV-56248, Albuterol sulfate | Teva Branded Pharmaceutical Products R&D, Inc. | Asthma | 07/26 | 07/26 | | |
NCT06271408: Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging |
|
|
| Recruiting | 1 | 6 | US | Albuterol Sulfate, 2.5 Mg/3 mL (0.083%) Inhalation Solution, Vibrating Mesh Nebulizer, Solo VMN, Metered Dose Inhaler, pMDI-aerosol metered dose inhaler, Jet Nebulizer, JN nebulizer | Polarean, Inc., Aerogen | Chronic Obstructive Pulmonary Disease | 04/24 | 04/24 | | |
NCT04901715: Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype |
|
|
| Recruiting | 1 | 30 | US | Albuterol, ProAir HFA (hydrofluoroalkane) Inhaler, Ventolin HFA (hydrofluoroalkane) Inhaler, Technetium99m - Sulfur Colloid (Tc99m-SC) | University of North Carolina, Chapel Hill, National Heart, Lung, and Blood Institute (NHLBI) | Primary Ciliary Dyskinesia | 04/25 | 04/25 | | |
NCT06290102: Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old |
|
|
| Recruiting | 1 | 22 | US | TEV-56248, - fluticasone propionate/albuterol sulfate multidose dry powder inhaler with e-module (Fp/ABS eMDPI), Fp MDPI, - fluticasone propionate multidose dry powder inhaler | Teva Branded Pharmaceutical Products R&D, Inc. | Asthma | 10/24 | 11/24 | | |
NCT05035862: Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma |
|
|
| Recruiting | 1 | 12 | US | Albuterol Sulfate, Interferon gamma-primed mesenchymal stromal cells (MSCs), Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells, Prednisone | Emory University, The Marcus Foundation, Ossium Health, Inc. | Asthma | 07/25 | 12/25 | | |
NCT05241288: Digihaler in Chronic Obstructive Pulmonary Disease (COPD) |
|
|
| Completed | N/A | 54 | US | Albuterol eMDPI DS, ProAir® Digihaler® | University of North Carolina, Chapel Hill, Wake Forest University Health Sciences, Teva Branded Pharmaceutical Products R&D, Inc. | Pulmonary Disease, Chronic Obstructive | 02/23 | 02/23 | | |
NCT04912596: Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma |
|
|
| Recruiting | N/A | 148 | RoW | Albuterol Sulfate inhalation aerosol 108 mcg per actuation, Albuterol Sulfate, Proair HFA (Albuterol Sulfate) or FDA authorized generic: Albuterol Sulfate HFA (Teva Pharmaceutical USA, Inc.) Inhalation Aerosol 108 mcg per actuation, Proair HFA or FDA authorized generic: Albuterol Sulfate HFA Inhalation Placebo, Albuterol Sulfate inhalation Placebo, Methacholine | Intech Biopharm Ltd. | Mild Asthma | 03/24 | 04/24 | | |
| Recruiting | N/A | 50 | | | south valley university , south valley university, Qena university hospital | we will study the effect of adding aerosolized albuterol to lung recruitment maneuver during the managment of ALI due to surgical and non-surgical causes e.g acute lung injury following aspiration pneumonia , abdominal sepsis, pancreatitis, chest trauma , lobectomy,and so on | | | | |
